In pancreatic cancer, inhibition of AQP3 by the inhibitor CuSO4 attenuated tumor cell migration, which suggested it was a potential therapeutic treatment agent for pancreatic cancer [96]. Here, AQP3 is linked to pancreatic neoplasm.